USA TODAY: Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026 Moderna to Present Revaccination Data for Its Investigational Seasonal Influenza Vaccine and for mRESVIA at ESCMID 2026 Infectious Disease Advisor: COVID-19 Mortality Rates Decline but Remain Comparable to Influenza A Thirty-day COVID-19 mortality rates have declined since 2020 but remain comparable to or slightly higher than influenza A mortality rates in recent years. A new flu treatment could drastically reduce one of flu's deadliest complications—bacterial pneumonia—by helping the lungs defend themselves, rather than targeting the virus directly. Influenza ...
ABC (Australian Broadcasting Corporation): Australia's 2026 influenza vaccine rollout and the Super-K strain Experts say they are feeling "nervous" as Australia approached this year's flu season, with a new, fast-moving strain of influenza dubbed "Super-K" circulating as vaccine uptake dwindles. Infectious Disease Advisor: Influenza Vaccine Linked to Lower Hospitalization Risk During 2025 to 2026 Season The 2025-2026 flu vaccine reduced influenza-related outpatient visits and hospitalizations despite an antigenically drifted A(H3N2) strain. Influenza Vaccine Linked to Lower Hospitalization Risk During 2025 to 2026 Season A population-based study, published in Clinical Microbiology and Infection and due to be presented next week at ESCMID Global 2026, has found that influenza was detected in 11% of winter deaths, yet ... National Hog Farmer: Pigs bridge gaps in influenza research and vaccine development Essential tools for understanding viral evolution, monoclonal anitbodies guide therapeutic development and inform vaccine design.
influenza influenza, While influenza mAb development in humans has progressed rapidly, ... As an aid for our readers, and for a little amusement, here is a 10-question quiz based on the news of the week. Topics include influenza vaccination and Alzheimer's disease, potential concerns about ...
